A spectroscopic serum based blood test for brain tumours: Optimisation for high-throughput sampling and the health economic impacts


It has recently been demonstrated that a spectroscopic test using blood-serum is able to effectively identify brain tumours in patients with sensitivities and specificities as high as 91.5% and 83% respectively. The approach... [ view full abstract ]


  1. Holly Butler (University of Strathclyde)
  2. Matthew Baker (University of Strathclyde)
  3. Mark Hegarty (ClinSpec Dx)
  4. Duncan Finlayson (University of Strathclyde)

Topic Area

Laboratory and Clinical Science


OS-22F » Parallel Session F: Clinical (16:00 - Thursday, 22nd June, Prestonfield)

Presentation Files

The presenter has not uploaded any presentation files.